Hmmm... thanks again MedTech. This could explain Austco's return...

First 7 Last

Share
Profile

Follow
JazzMan2

71 Posts.

02/12/15

18:33

Post #: 16532485
Share

Originally posted by MedTech ↑

Hi Jazzman,

Without discussing AZV specifically, If I could answer in a more generic fashion:

Nursecall Systems are considered a Class II Medical Device, exempt from 510(k) (Pre-Market Approval). This means that you must list your medical device with the FDA and undertake to comply with QSR820. QSR820 is a similar standard to ISO13485, which in turn is a super standard of ISO9001. Like all quality systems, there is an implementation cost associated with its deployment and an ongoing maintenance cost of the quality system. Specifically with QSR820, which is designed for medical devices, it is important to track versions of products, have formalized risk analysis, audits et al - my experience has been about a 10% increase in costs for manufacturing and research and development expenses, with a small, incremental cost associated with Sales, Marketing and Management.

However, in saying the above, once the system is rolled out, then quality increases and your real costs decrease - but it takes several years to fine tune everything (at least in my experience!).

However, once you cross the threshold into integrating Point of Care Devices, such as patient monitors, then you move into the 510(k) arena, which incurs additional costs and regularity compliance.

I trust the above assists.

Expand

Hmmm... thanks again MedTech. This could explain Austco's return to an emphasis on being a "Nurse Call Solutions" provider on it's new web site.... and very little said in relation to the previous emphasis on "clinical integration and workflow management". If you're right then such integration may push them into the 510(k) area would it not?

Also interesting is that the new website does not list secure care as a market. Wonder what's happening to it's prison product range. May be in the 600 products they're going to cut.

Jazzman

AZV Price at posting: 9.8¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 8 more messages in this thread...

First 7 Last

Add AZV (ASX) to my watchlist

Hmmm... thanks again MedTech. This could explain Austco's return...

Top Stories

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025